Literature DB >> 8205876

Recovery of viruses other than cytomegalovirus from bronchoalveolar lavage fluid.

M G Connolly1, R P Baughman, M N Dohn, C C Linnemann.   

Abstract

STUDY
DESIGN: To determine the yield and diagnostic significance of performing viral cultures on specimens obtained by bronchoalveolar lavage (BAL) in immunocompromised patients.
DESIGN: Review of all BAL specimens submitted for viral culture over a six-year period.
SETTING: Referral laboratory within a university hospital. The majority of specimens came from the university hospital, and for those cases, review of the patient's underlying disease, clinical presentation, and outcome was performed. PATIENTS: Over 95 percent of the patients had recognized underlying immunosuppression. INTERVENTION: None. MEASUREMENTS AND
RESULTS: Cultures were done on 1,199 BAL specimens for viruses, and in 90 (8 percent), non-cytomegalovirus (CMV) viruses were recovered. These included herpes virus (53), influenza (11), parainfluenza (7), rhinovirus (12), adenovirus (5), enterovirus (1), and respiratory syncytial virus (1). Complete medical records were available for 1,020 (85 percent) of the BAL specimens, and the 77 patients with non-CMV viral pneumonia were studied in more detail. In 31 (40 percent) patients, virus was the only potential pathogen recovered.
CONCLUSION: The recovery of respiratory viruses followed epidemic trends in the community and was often associated with self-limited illnesses without an increased mortality. The isolation of herpesvirus in patients without AIDS was associated with increased mortality in comparison with patients with AIDS (p < 0.01). This study demonstrates that viruses other than CMV may be recovered from BAL of patients with lower respiratory disease and may be the only pathogen recovered.

Entities:  

Mesh:

Year:  1994        PMID: 8205876     DOI: 10.1378/chest.105.6.1775

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  9 in total

Review 1.  Current research on respiratory viral infections: Third International Symposium.

Authors:  A C Schmidt; R B Couch; G J Galasso; F G Hayden; J Mills; B R Murphy; R M Chanock
Journal:  Antiviral Res       Date:  2001-06       Impact factor: 5.970

2.  Management of herpes simplex virus type 1 pneumonia following liver transplantation.

Authors:  P Liebau; E Kuse; M Winkler; H J Schlitt; K Oldhafer; W Verhagen; J Flik; R Pichlmayr
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

3.  Constrictive bronchiolitis obliterans with a presumptive etiology of preceding feline herpesvirus infection in a cat.

Authors:  Pin-I Hsieh; Hui-Wen Chen; Hsiao-Ning Yeh; Man-Cham Lam; Pei-Ying Lo; Wei-Hsiang Huang; Cheng-Hsin Shih; Chung-Hui Lin
Journal:  BMC Vet Res       Date:  2022-07-05       Impact factor: 2.792

4.  Clinical characteristics and outcomes of severe rhinovirus-associated pneumonia identified by bronchoscopic bronchoalveolar lavage in adults: comparison with severe influenza virus-associated pneumonia.

Authors:  Sang-Ho Choi; Jin Won Huh; Sang-Bum Hong; Ju Young Lee; Sung-Han Kim; Heungsup Sung; Kyung-Hyun Do; Sang-Oh Lee; Mi-Na Kim; Jin-Yong Jeong; Chae-Man Lim; Yang Soo Kim; Jun Hee Woo; Younsuck Koh
Journal:  J Clin Virol       Date:  2014-11-15       Impact factor: 3.168

Review 5.  Utility of animal and in vivo experimental infection of humans with rhinoviruses in the development of therapeutic agents for viral exacerbations of asthma and chronic obstructive pulmonary disease.

Authors:  Alfred M Del Vecchio; Patrick J Branigan; Elliot S Barnathan; Susan K Flavin; Philip E Silkoff; Ronald B Turner
Journal:  Pulm Pharmacol Ther       Date:  2014-11-13       Impact factor: 3.410

6.  Rhinovirus infections in hematopoietic stem cell transplant recipients with pneumonia.

Authors:  Michael G Ison; Frederick G Hayden; Laurent Kaiser; Lawrence Corey; Michael Boeckh
Journal:  Clin Infect Dis       Date:  2003-04-21       Impact factor: 9.079

7.  Diagnosis of influenza from lower respiratory tract sampling after negative upper respiratory tract sampling.

Authors:  Isaac I Bogoch; Jason R Andrews; Kimon C Zachary; Elizabeth L Hohmann
Journal:  Virulence       Date:  2012-11-07       Impact factor: 5.882

8.  Clinical severity of rhinovirus/enterovirus compared to other respiratory viruses in children.

Authors:  Sandra A Asner; Astrid Petrich; Jemila S Hamid; Dominik Mertz; Susan E Richardson; Marek Smieja
Journal:  Influenza Other Respir Viruses       Date:  2014-05-07       Impact factor: 4.380

9.  Detection of severe human metapneumovirus infection by real-time polymerase chain reaction and histopathological assessment.

Authors:  Kaharu C Sumino; Eugene Agapov; Richard A Pierce; Elbert P Trulock; John D Pfeifer; Jon H Ritter; Monique Gaudreault-Keener; Gregory A Storch; Michael J Holtzman
Journal:  J Infect Dis       Date:  2005-08-04       Impact factor: 5.226

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.